NAMS
NASDAQ · Biotechnology
Newamsterdam Pharma Co Nv
$27.96
+0.29 (+1.05%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
+30.2% upside
Low Target
$23.00
Average Target
$36.39
High Target
$47.36
Current Price
$27.96
Current
$27.96
$27.96
Target
$36.39
$36.39
$23.00
$36.39 avg
$47.36
Scenario Analysis
Bear Case
$23.00
-17.7%
Low target
Base Case
$36.39
+30.2%
Avg target
Bull Case
$47.36
+69.4%
High target
Risk/Reward
3.9x
Highly favorable
Price in Context
52-Week High
$42.21
-33.8% from high
52-Week Low
$21.23
+31.7% from low
50-Day SMA
$34.11
-18.0% vs SMA
200-Day SMA
$28.53
-2.0% vs SMA
RSI (14)
66.1
Neutral
Target vs 52W High
$36.39
-13.8% vs high
Next Earnings Report
Aug 12, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.50
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |